Share

HVTN & Merck: press briefing on data from STEP study

WHAT: Press briefing on STEP study data

WHO: Lawrence Corey, M.D., principal investigator, HVTN and co-director of Vaccine and Infectious Disease Institute at Fred Hutchinson Cancer Research Center
Margaret I. Johnston, Ph.D., director, Vaccine Research Program in the Division of AIDS, National Institute of Allergy and Infectious Diseases
Keith Gottesdiener, M.D., vice president, Clinical Research, Merck Research Laboratories

WHEN: Wednesday, Nov. 7, 2007
1-2 p.m. PST
Early call-in and login recommended.

WHERE: Grand Hyatt Hotel, Stevens Boardroom, 7th Floor, 721 Pine St, Seattle, WA 98101

ONLINE: Click on the following link to access the press briefing via WebEx.
https://stepdata.webex.com/stepdata/onstage/g.php?t=a&d=666029292 (a password is not required to join online)

Early registration is encouraged.

If you experience technical difficulties, please contact WebEx Technical Support at (866) 229-3239

Teleconference details:

I. Dial-in Domestic Toll Free (US and Canada): (800) 203-2706
Participant Passcode: 887 422 43

II. Dial-in international toll-free numbers available for these countries:
Australia: 1800.00.2971
Brazil: 0008.172.005.239
South Africa: 0800.99.6636
UK: 0-808-234-7616
Participant Passcode: 887 422 43

III. All other international callers: (617) 614-3680
Participant Passcode: 887 422 43

For previously reported information on the STEP study and another phase II clinical trial with Merck's investigational HIV vaccine (V520), visit:

http://www.merck.com/newsroom/press_releases/research_and_development/2007_0921.html

http://www3.niaid.nih.gov/news/newsreleases/2007/step_statement.htm

http://www3.niaid.nih.gov/news/newsreleases/2007/step_update.htm

Share

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.